# US 2023/0054162 A1 · Methods for producing oil-in-water emulsions

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0054162 A1
- Document ID: US20230054162A1
- Status: Published application
- Kind: A1
- Application number: 17/787,478
- Filed: 2020-12-18
- Published: 2023-02-23
- Earliest claimed: 2019-12-20
- Applicants: Fresenius Kabi Austria GmbH
- Inventors: Andreas Heinrich JUNG; Christoph KOTH; Peter Gerhard STADLER
- Web page: https://patentgrep.com/patent/US20230054162A1

## CPC

- A61K 9/0019: {Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner (non-active ingredients are additionally classified in A61K47/00)}
- A61K 9/1075: {Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers (A61K9/0026 takes precedence)}
- A61K 9/0029: {Parenteral nutrition; Parenteral nutrition compositions as drug carriers}
- A61K 47/44: Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin (synthetic glycerides, e.g. medium-chain triglycerides, A61K47/14)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

The present invention relates to a highly efficient method for producing oil-in-water emulsions, preferably for parenteral administration, which method is characterized in that large parts of the water phase are added only after the energy-intensive homogenization of the pre-emulsion, i.e. an emulsion having low water content is first produced and said emulsion is subsequently “diluted”.

## Claims

### Claim 1

A method for producing an oil-in-water emulsion, comprising a water phase and 1 to 40% of an oil phase, in relation to the total weight of the emulsion, wherein the method comprises the following steps:
a) providing an oil phase, comprising one or a plurality of oils selected from the group consisting of animal oils, microbially produced oils, algae oils, fungal oils, synthetic or partially synthetic oils and vegetable oils; and,
optionally a pharmaceutically acceptable antioxidant and/or at least one pharmaceutically acceptable co-emulsifier;
b) providing a water phase 1, comprising water and optionally at least one pharmaceutically acceptable co-emulsifier and/or at least one substance for setting the pH value and/or at least one pharmaceutically acceptable preservative and/or at least one pharmaceutically acceptable isotonic agent, wherein the isotonic agent is present in a concentration of at most 18%, in relation to the total weight of the water phase;
c) producing a pre-emulsion by mixing the oil phase, provided in step a), with the water phase 1, provided in step b);
d) producing a first emulsion by homogenizing the pre-emulsion, provided in step c);
e) providing a water phase 2, comprising water and optionally at least one pharmaceutically acceptable isotonic agent and/or at least one substance for setting the pH value and/or at least one pharmaceutically acceptable preservative;
f) producing the emulsion by mixing the first emulsion, provided in step d), with the water phase 2, provided in step e); and
g) sterilizing the emulsion, obtained in step f);
wherein the emulsion is filled into a suitable container before or after being sterilized;
wherein at least one pharmaceutically acceptable emulsifier is added in step a) and/or in step b); and
wherein the water phase 1, provided in step b), provides no more than 30% of the total amount of water contained in the emulsion.

### Claim 2 (depends on 1)

The method according to claim 1, wherein the emulsion is provided for parenteral administration and wherein the water used for providing the water phases 1 and 2 in the steps b) and e) is water for injection purposes (WFI).

### Claim 3 (depends on 1)

The method according to claim 1, wherein the pharmaceutically acceptable emulsifier is added in a concentration of 0.1 to 5% in relation to the total weight of the emulsion.

### Claim 4 (depends on 1)

The method according to claim 1, wherein the pharmaceutically acceptable emulsifier is lecithin.

### Claim 5 (depends on 1)

The method according to claim 1, wherein the pharmaceutically acceptable co-emulsifier is sodium oleate and is added in step b).

### Claim 6 (depends on 1)

The method according to claim 1, wherein the pharmaceutically acceptable co-emulsifier is oleic acid and is added in step a).

### Claim 7 (depends on 1)

The method according to claim 1, wherein the oil-in-water emulsion comprises a pharmaceutically acceptable isotonic agent.

### Claim 8 (depends on 1)

The method according to claim 1, wherein the pharmaceutically acceptable isotonic agent is a polyol.

### Claim 9 (depends on 1)

The method according to claim 1, wherein the pharmaceutically acceptable isotonic agent is added in step b).

### Claim 10 (depends on 1)

The method according to claim 1, wherein the pharmaceutically acceptable isotonic agent is present in step b) in a concentration of at most 15% in relation to the total weight of the water phase 1.

### Claim 11 (depends on 1)

The method according to claim 1, wherein the isotonic agent is exclusively added in step e).

### Claim 12

(canceled)

### Claim 13 (depends on 1)

The method according to claim 1, wherein the oil phase comprises a vegetable oil and/or an animal oil.

### Claim 14 (depends on 1)

The method according to claim 1, wherein the oil phase comprises soybean oil, medium-chain triglycerides, olive oil, structured lipids, fish oil, fish oil extract, krill oil or mixtures thereof

### Claim 15

(canceled)

### Claim 16 (depends on 1)

The method according to claim 1, wherein the oil phase comprises soybean oil, medium-chain triglycerides, olive oil and fish oil.

### Claim 17 (depends on 1)

The method according to claim 1, wherein the oil phase comprises 25 to 35% soybean oil, 25 to 35% MCTs, 20 to 30% olive oil and 10 to 20% fish oil in relation to the total weight of the oil phase.

### Claim 18

(canceled)

### Claim 19

(canceled)

### Claim 20 (depends on 1)

The method according to claim 1, wherein the PFAT5 value of the emulsion, obtained in step d), and the emulsion, obtained in step f), before and after being sterilized in step g) is below 0.05%.

### Claim 21 (depends on 1)

The method according to claim 1, wherein the average PFAT5 value of the emulsion, obtained in step d), and in the emulsion, obtained in step f), before and after being sterilized in step g), is below 0.035%.

### Claim 22 (depends on 1)

The method according to claim 1, wherein one or a plurality of drugs and/or one or a plurality of vitamins are added in step a) and/or in step b) and/or in step e) and/or in step f).

### Claim at position 23

23-27. (canceled)

### Claim 28 (depends on 1)

An oil-in-water emulsion, comprising a water phase and 1 to 40% of an oil phase in relation to the total weight of the emulsion, obtained in accordance with the method according to claim 1.

### Claim 29

(canceled)

### Claim 30

An oil in water emulsion said emulsion prepared according to a method comprising a water phase and 1 to 40%, in relation to the total weight of the emulsion, wherein the method comprises the following steps:
a) providing an oil phase, comprising one or a plurality of oils selected from the group consisting of animal oils, microbially produced oils, algae oils, fungal oils, synthetic or partially synthetic oils and vegetable oils; and,
optionally a pharmaceutically acceptable antioxidant and/or at least one pharmaceutically acceptable co-emulsifier;
b) providing a water phase 1, comprising water and optionally at least one pharmaceutically acceptable co-emulsifier and/or at least one substance for setting the pH value and/or at least one pharmaceutically acceptable preservative and/or at least one pharmaceutically acceptable isotonic agent, wherein the isotonic agent is present in a concentration of at most 18%, in relation to the total weight of the water phase;
c) producing a pre-emulsion by mixing the oil phase, provided in step a), with the water phase 1, provided in step b);
d) producing an emulsion by homogenizing the pre-emulsion, provided in step c).
